BPK Bespak

RNS Number:5396E
Bespak PLC
26 September 2007


                                   Bespak plc

                              Annual General Meeting


John Robinson, Chairman of Bespak plc will today confirm at the Annual General
Meeting an excellent performance over the year.

"After two years of profit growth in excess of 20%, the Company remains on
target to double 2005/6 profit before tax within five years. In setting this
target we recognize that profit growth will be irregular and do not expect
steady linear progress toward our goal.

"As announced in our interim management statement, trading is in line with the 
Board's expectations. The Company has completed a consultation process with 160 
employees at its Milton Keynes site, and this has resulted in 53 redundancies 
and the elimination of 49 temporary positions.

"The Company will propose a Resolution today at the AGM for the change of the
name of the Company to Consort Medical plc. This name change reflects the
company's strategy to focus on medical devices. The Bespak brand name will be
retained in the Inhaled Drug Delivery business segment and the King Systems
brand in the anaesthesia segment."

For further information, please contact:

Bespak plc                                  Tel: +44 (0) 1908 525 240
Mark Throdahl - Chief Executive
Jon Glenn - Finance Director

Maitland                                    Tel: +44 (0) 207 379 5151
Brian Hudspith Liz Morley




                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
AGMSEEFLMSWSESU

Grafico Azioni Bespak (LSE:BPK)
Storico
Da Feb 2025 a Mar 2025

Grafico Azioni Bespak (LSE:BPK)
Storico
Da Mar 2024 a Mar 2025